ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,854, issued on March 24, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"KRAS G12C inhibitors and methods of using the same" was invented by Jian Chen (Camarillo, Calif.), Nuria A. Tamayo (Newbury Park, Calif.), Longbin Liu (Thousand Oaks, Calif.), Hui-Ling Wang (Thousand Oaks, Calif.), Brian Alan Lanman (Woodland Hills, Calif.), Ryan Paul Wurz (Newbury Park, Calif.), Youngsook Shin (Thousand Oaks, Calif.) and Victor J. Cee (Thousand Oaks, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are KRAS G12C inhibitors, such ascomposition of the same, and methods of using the same. These inhibitors are useful for treating a numbe...